Skip to content
Alcyone Tx
Contact
About
Our Company
Our Team
Scientific Advisors
Board of Directors
Strategic Collaborators
Patient Advisory Committee
Science & Technology
Our Approach
Platforms
Gene Replacement
X-Reactivation
Vectorized Exon Skipping
Promoter Modulation
CMC
Falcon
Publications
Pipeline & Programs
Pipeline
ACTX-401
ACTX-101
Investors & Media
Investors
Press Releases
Careers
Contact
Investors & Media
Press
Releases
Select year:
2021
2022
2021
2019
October 25, 2021
Alcyone Therapeutics Strengthens Executive Team with New Senior Leadership Appointments
June 9, 2021
Alcyone Therapeutics Launches to Advance Next-Generation Gene Therapies for CNS Disorders with $23 Million in Funding Contribution from RTW Investments
